Grace Therapeutics, Inc. (GRCE)
SG&A Expense Growth
-15.03%
Fiscal year · Period ending:
GRCE SG&A Expense Growth
Latest reported-15.03%period ending
Latest reported-15.03%period ending
GRCE FY SG&A Growth (YoY) (0.00% → -15.03%)
Latest values, visible window
High-resolution chart · PNG
GRCE sg&a expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| -15.0328% | |
| 13.1109% | |
| -18.8261% | |
| -9.1163% | |
| 16.3623% | |
| -37.901% | |
| 294.0521% | |
| 37.6392% | |
| 305.6364% | |
| -49.0845% | |
| -47.1294% | |
| -35.8015% | |
| 6.1881% | |
| 18.0059% | |
| 115.8057% | |
| 302.5894% | |
| -25.6764% | |
| 0% |